Spots Global Cancer Trial Database for recurrent adult brain neoplasm

Every month we try and update this database with for recurrent adult brain neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma	NCT00423735	Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult...	Dasatinib Pharmacological...	18 Years -	National Cancer Institute (NCI)
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma	NCT01378481	Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult...	Vorinostat Stereotactic Ra... Laboratory Biom... Pharmacological... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma	NCT02101905	Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Gliosarcoma Mixed Glioma Recurrent Adult... Recurrent Gliob...	Laboratory Biom... Lapatinib Lapatinib Ditos... Pharmacological... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma	NCT00329719	Adult Glioblast... Adult Gliosarco... Recurrent Adult...	Conventional Su... Laboratory Biom... Sorafenib Tosyl... Temsirolimus	18 Years -	National Cancer Institute (NCI)
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma	NCT00823797	Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult...	Bendamustine Hy... Quality-of-Life...	18 Years -	University of Washington
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma	NCT01051557	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	Laboratory Biom... Perifosine Temsirolimus Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma	NCT00979862	Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult...	Cediranib Malea... Cilengitide Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas	NCT00268385	Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult...	Laboratory Biom... Pharmacological... Temozolomide Vorinostat	18 Years -	National Cancer Institute (NCI)
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma	NCT02101905	Anaplastic Astr... Anaplastic Epen... Anaplastic Olig... Gliosarcoma Mixed Glioma Recurrent Adult... Recurrent Gliob...	Laboratory Biom... Lapatinib Lapatinib Ditos... Pharmacological... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma	NCT01817751	Glioblastoma Recurrent Adult... Malignant Gliom... WHO Grade III G...	sorafenib tosyl... valproic acid sildenafil citr...	18 Years -	Virginia Commonwealth University
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma	NCT01051557	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	Laboratory Biom... Perifosine Temsirolimus Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor	NCT00049127	Adult Anaplasti... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	Imatinib Mesyla... Laboratory Biom... Pharmacological...	18 Years -	Alliance for Clinical Trials in Oncology
High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma	NCT01378481	Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult...	Vorinostat Stereotactic Ra... Laboratory Biom... Pharmacological... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme	NCT01122888	Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Solid Neo... Recurrent Adult...	Cilengitide Clinical Observ... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma	NCT00979862	Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult...	Cediranib Malea... Cilengitide Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas	NCT00268385	Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult...	Laboratory Biom... Pharmacological... Temozolomide Vorinostat	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: